NASDAQ:BJDX - US0956335097 - Common Stock
The current stock price of BJDX is 1.3614 USD. In the past month the price decreased by -9.24%. In the past year, price decreased by -85.42%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.07 | 230.89B | ||
ISRG | INTUITIVE SURGICAL INC | 58.79 | 169.67B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.28 | 156.32B | ||
SYK | STRYKER CORP | 30.46 | 149.64B | ||
MDT | MEDTRONIC PLC | 16.78 | 119.05B | ||
BDX | BECTON DICKINSON AND CO | 13.52 | 55.31B | ||
IDXX | IDEXX LABORATORIES INC | 53.88 | 51.77B | ||
EW | EDWARDS LIFESCIENCES CORP | 31.65 | 47.75B | ||
RMD | RESMED INC | 28.74 | 40.19B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.82 | 33.66B | ||
DXCM | DEXCOM INC | 44.32 | 29.55B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 16.42 | 26.56B |
Bluejay Diagnostics, Inc. operates as a diagnostic company. The company is headquartered in Acton, Massachusetts and currently employs 7 full-time employees. The company went IPO on 2021-11-10. The company develops rapid tests using whole blood on its Symphony technology platform (Symphony), which consists of an analyzer and single-use protein detection cartridges that have the function of automatic stepwise feeding of reagent. The Symphony device is designed to produce laboratory-quality results in 20 minutes in critical care settings, including Intensive Care Units (ICUs) and Emergency Rooms (ERs). Its product candidate, the Symphony IL-6 test, is an immunoassay for the measurement of interleukin-6 (IL-6) to be used for the monitoring of disease progression in critical care settings. The company is focused on pursuing the Symphony IL-6 test in the context of sepsis. IL-6 is a clinically established inflammatory biomarker, and is considered a 'first-responder', for the assessment of severity of infection and inflammation across many disease indications, including sepsis.
BLUEJAY DIAGNOSTICS INC
360 Massachusetts Avenue, Suite 203
Acton MASSACHUSETTS US
Employees: 5
Phone: 19786310152
The current stock price of BJDX is 1.3614 USD. The price decreased by -0.63% in the last trading session.
The exchange symbol of BLUEJAY DIAGNOSTICS INC is BJDX and it is listed on the Nasdaq exchange.
BJDX stock is listed on the Nasdaq exchange.
BLUEJAY DIAGNOSTICS INC (BJDX) has a market capitalization of 2.03M USD. This makes BJDX a Nano Cap stock.
BLUEJAY DIAGNOSTICS INC (BJDX) currently has 5 employees.
BLUEJAY DIAGNOSTICS INC (BJDX) has a resistance level at 1.42. Check the full technical report for a detailed analysis of BJDX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BJDX does not pay a dividend.
BLUEJAY DIAGNOSTICS INC (BJDX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-40.34).
The outstanding short interest for BLUEJAY DIAGNOSTICS INC (BJDX) is 3.87% of its float. Check the ownership tab for more information on the BJDX short interest.
ChartMill assigns a fundamental rating of 2 / 10 to BJDX. While BJDX seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months BJDX reported a non-GAAP Earnings per Share(EPS) of -40.34. The EPS increased by 97.11% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -311.68% | ||
ROE | -377.26% | ||
Debt/Equity | 0 |